<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "2: should carefully", fill: "#f0e68c"},
{source: "2: should carefully", target: "2: risks described", fill: "#f0e68c"},
{source: "2: risks described", target: "2: Axonyx ", fill: "#f0e68c"},
{source: "2: should carefully", target: "3: following risks actually", fill: "#d70040"},
{source: "3: following risks actually", target: "5: forwardlooking", fill: "#6e7f80"},
{source: "5: forwardlooking", target: "5: statements about future", fill: "#6e7f80"},
{source: "5: statements about future", target: "5: objectives", fill: "#6e7f80"},
{source: "5: objectives", target: "5: intentions", fill: "#6e7f80"},
{source: "5: intentions", target: "5: involve risks", fill: "#6e7f80"},
{source: "5: involve risks", target: "5: uncertainties", fill: "#6e7f80"},
{source: "5: forwardlooking", target: "6: materially", fill: "#98777b"},
{source: "6: materially", target: "6: forwardlooking", fill: "#98777b"},
{source: "6: materially", target: "7: differences", fill: "#4f666a"},
{source: "7: differences", target: "8: clinical trial failures on", fill: "#c72"},
{source: "8: clinical trial failures on", target: "9: statistical significance", fill: "#e7feff"},
{source: "9: statistical significance", target: "9: endpoints", fill: "#e7feff"},
{source: "9: endpoints", target: "9: Phase III ", fill: "#e7feff"},
{source: "9: Phase III ", target: "9: trials conducted", fill: "#e7feff"},
{source: "9: trials conducted", target: "9: lead compound", fill: "#e7feff"},
{source: "9: statistical significance", target: "10: development", fill: "#872657"},
{source: "10: development", target: "10: Phenserine ", fill: "#872657"},
{source: "10: Phenserine ", target: "10: conducting additional", fill: "#872657"},
{source: "10: conducting additional", target: "10: Phase III ", fill: "#872657"},
{source: "10: development", target: "12: cannot assure", fill: "#e3dac9"},
{source: "12: cannot assure", target: "12: successfully", fill: "#e3dac9"},
{source: "12: cannot assure", target: "13: Phenserine ", fill: "#ff0"},
{source: "13: Phenserine ", target: "13: will successfully", fill: "#ff0"},
{source: "13: will successfully", target: "13: commercialize", fill: "#ff0"},
{source: "13: Phenserine ", target: "14: defendant", fill: "#78184a"},
{source: "14: defendant", target: "14: action lawsuit", fill: "#78184a"},
{source: "14: action lawsuit", target: "14: shareholder derivative lawsuit which", fill: "#78184a"},
{source: "14: shareholder derivative lawsuit which", target: "14: adversely could", fill: "#78184a"},
{source: "14: adversely could", target: "14: adverse affect on us", fill: "#78184a"},
{source: "14: defendant", target: "15: action securities lawsuit", fill: "#e4717a"},
{source: "15: action securities lawsuit", target: "15: shareholder derivative", fill: "#e4717a"},
{source: "15: action securities lawsuit", target: "START_HERE", fill: "#e4717a"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Accuse</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Prince">The Prince</a></td>
      <td>The Prince (Italian: Il Principe [il ˈprintʃipe]; Latin: De Principatibus) is a 16th-century political treatise written by Italian diplomat and political theorist Niccolò Machiavelli as an instruction guide for new princes and royals. The general theme of The Prince is of accepting that the aims of princes – such as glory and survival – can justify the use of immoral means to achieve those ends.From Machiavelli's correspondence, a version appears to have been distributed in 1513, using a Latin title, De Principatibus (Of Principalities).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Health_risks_from_dead_bodies">Health risks from dead bodies</a></td>
      <td>The health risks of dead bodies are dangers related to the improper preparation and disposal of cadavers. While normal circumstances allow cadavers to be quickly embalmed, cremated, or buried, natural and man-made disasters can quickly overwhelm and/or interrupt the established protocols for dealing with the dead.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/International_Financial_Reporting_Standards">International Financial Reporting Standards</a></td>
      <td>International Financial Reporting Standards, commonly called IFRS, are accounting standards issued by the IFRS Foundation and the International Accounting Standards Board (IASB). They constitute a standardised way of describing the company's financial performance and position so that company financial statements are understandable and comparable across international boundaries.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Pricing_objectives">Pricing objectives</a></td>
      <td>Pricing objectives or goals give direction to the whole pricing process. Determining what your objectives are is the first step in pricing.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Alternative_risk_transfer">Alternative risk transfer</a></td>
      <td>Alternative risk transfer (often referred to as ART) is the use of techniques other than traditional insurance and reinsurance to provide risk-bearing entities with coverage or protection.  The field of alternative risk transfer grew out of a series of insurance capacity crises in the 1970s through 1990s that drove purchasers of traditional coverage to seek more robust ways to buy protection.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Cock_and_ball_torture">Cock and ball torture</a></td>
      <td>Cock and ball torture (CBT), occasionally known as penis torture, dick torture, or male genitorture/male genital torture,  is a sexual activity involving the application of pain or constriction to the penis or testicles. This may involve directly painful activities, such as genital piercing, wax play, genital spanking, squeezing, ball-busting, genital flogging, urethral play, tickle torture, erotic electrostimulation, kneeing or kicking.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Measurement_uncertainty">Measurement uncertainty</a></td>
      <td>In metrology, measurement uncertainty is the expression of the statistical dispersion of the values attributed to a measured quantity. All measurements are subject to uncertainty and a measurement result is complete only when it is accompanied by a statement of the associated uncertainty, such as the standard deviation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Uncertainty_budget">Uncertainty budget</a></td>
      <td>The uncertainty budget is an aid for specifying the expanded measurement uncertainty. The individual measurement uncertainty factors are summarised, usually in tabular form, in the measurement uncertainty budget.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Lime_(material)">Lime (material)</a></td>
      <td>Lime is a calcium-containing inorganic mineral composed primarily of  oxides, and hydroxide, usually calcium oxide and/or calcium hydroxide. It is also the name for calcium oxide which occurs as a product of coal-seam fires and in altered limestone xenoliths in volcanic ejecta.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Difference_in_differences">Difference in differences</a></td>
      <td>Difference in differences (DID or DD) is a statistical technique used in econometrics  and quantitative research in the social sciences that attempts to mimic an experimental research design using observational study data, by studying the differential effect of a treatment on a 'treatment group' versus a 'control group' in a natural experiment. It calculates the effect of a treatment (i.e., an explanatory variable or an independent variable) on an outcome (i.e., a response variable or dependent variable) by comparing the average change over time in the outcome variable for the treatment group to the average change over time for the control group.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Clinical_trial">Clinical trial</a></td>
      <td>Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Randomized_controlled_trial">Randomized controlled trial</a></td>
      <td>A randomized controlled trial (or randomized control trial; RCT) is a form of scientific experiment used to control factors not under direct experimental control. Examples of RCTs are clinical trials that compare the effects of drugs, surgical techniques, medical devices, diagnostic procedures or other medical treatments.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Analysis_of_clinical_trials">Analysis of clinical trials</a></td>
      <td>The analysis of clinical trials involves many related topics including:\n\nthe choice of an estimand (measure of effect size) of interest that is closely linked to the objectives of the trial,\nthe choice and definition of analysis sets,\nthe choice of an appropriate statistical model for the type of data being studied,\nappropriate accounting for the treatment assignment process,\nhandling of missing data,\nhandling of multiple comparisons or endpoints,\naccounting for interim analyses and trial adaptations,\nand appropriate data presentation.One basic guidance document on this topic is the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use guidance E9.\n\n\n== Choice of analysis set ==\nFailure to include all participants in the analysis may bias the trial results.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Statistics">Statistics</a></td>
      <td>Statistics is the discipline that concerns the collection, organization, analysis, interpretation, and presentation of data. In applying statistics to a scientific, industrial, or social problem, it is conventional to begin with a statistical population or a statistical model to be studied.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Stephen_Ziliak">Stephen Ziliak</a></td>
      <td>Stephen T. Ziliak (born October 17, 1963) is an American professor of economics whose research and essays span disciplines from statistics and beer brewing to medicine and poetry. He is currently a faculty member of the Angiogenesis Foundation, conjoint professor of business and law at the University of Newcastle in Australia, and professor of economics at Roosevelt University in Chicago, IL. He previously taught for the Georgia Institute of Technology, Emory University, and Bowling Green State University.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Line_segment">Line segment</a></td>
      <td>In geometry, a line segment is a part of a line that is bounded by two distinct end points, and contains every point on the line that is between its endpoints. A closed line segment includes both endpoints, while an open line segment excludes both endpoints; a half-open line segment includes exactly one of the endpoints.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Communication_endpoint">Communication endpoint</a></td>
      <td>A communication endpoint is a type of communication network node. It is an interface exposed by a communicating party or by a communication channel.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Subsequent_Nuremberg_trials">Subsequent Nuremberg trials</a></td>
      <td>The subsequent Nuremberg trials were a series of 12 military tribunals for war crimes against members of the leadership of Nazi Germany between December 1946 and April 1949. They followed the first and best-known Nuremberg trial before the International Military Tribunal which concluded in October 1946.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Sustainable_development">Sustainable development</a></td>
      <td>Sustainable development is an organizing principle for meeting human development goals while also sustaining the ability of natural systems to provide the natural resources and ecosystem services on which the economy and society depend. The desired result is a state of society where living conditions and resources are used to continue to meet human needs without undermining the integrity and stability of the natural system.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Acetylcholine">Acetylcholine</a></td>
      <td>Acetylcholine (ACh) is an organic chemical that functions in the brain and body of many types of animals (including humans) as a neurotransmitter. Its name is derived from its chemical structure: it is an ester of acetic acid and choline.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Butyrylcholinesterase">Butyrylcholinesterase</a></td>
      <td>Butyrylcholinesterase (HGNC symbol BCHE; EC 3.1.1.8), also known as BChE, BuChE, BuChase, pseudocholinesterase, or plasma (cholin)esterase, is a nonspecific cholinesterase enzyme that hydrolyses many different choline-based esters. In humans, it is made in the liver, found mainly in blood plasma, and encoded by the BCHE gene.It is very similar to the neuronal acetylcholinesterase, which is also known as RBC or erythrocyte cholinesterase.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Water_caltrop">Water caltrop</a></td>
      <td>The water caltrop is any of three extant species of the genus Trapa: Trapa natans, Trapa bicornis and the endangered Trapa rossica. It is also known as buffalo nut, bat nut, devil pod, ling nut, lin kok, ling jow,  ling kio nut, mustache nut or singhara.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/8_(Incubus_album)">8 (Incubus album)</a></td>
      <td>8 is the eighth studio album by American rock band Incubus. It was released on April 21, 2017, through Island Records.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Order_of_Australia">Order of Australia</a></td>
      <td>The Order of Australia is an honour that recognises Australian citizens and other persons for outstanding achievement and service. It was established on 14 February 1975 by Elizabeth II, Queen of Australia, on the advice of the Australian Government.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Z²">Z²</a></td>
      <td>Z² (short for Ziltoid 2; pronounced "zed squared" or alternatively "zee two") is a double album by Canadian musician Devin Townsend and his musical project Devin Townsend Project, released on October 27, 2014. It consists of two albums released together: the sixth album in the Devin Townsend Project series, the rock-oriented Sky Blue, and Dark Matters, a solo metal concept album acting as a sequel to Townsend's 2007 album Ziltoid the Omniscient.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/USC_Shoah_Foundation">USC Shoah Foundation</a></td>
      <td>USC Shoah Foundation – The Institute for Visual History and Education, formerly Survivors of the Shoah Visual History Foundation, is a nonprofit organization dedicated to making audio-visual interviews with survivors and witnesses of the Holocaust (which in Hebrew is called the Shoah) and other genocides, a compelling voice for education and action. It was established by Steven Spielberg in 1994, one year after completing his Academy Award-winning film Schindler's List.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Ageing">Ageing</a></td>
      <td>Ageing (BE) or aging (AE) is the process of becoming older. The term refers mainly to humans, many other animals, and fungi, whereas for example, bacteria, perennial plants and some simple animals are potentially biologically immortal.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Lawsuit">Lawsuit</a></td>
      <td>A lawsuit is a proceeding by a party or parties against another in the civil court of law. The archaic term "suit in law" is found in only a small number of laws still in effect today.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Direct-action_lawsuit">Direct-action lawsuit</a></td>
      <td>A direct-action lawsuit is brought directly against an insurance company for a wrong done by the insured.  \nIn a lawsuit that is not direct-action, a plaintiff brings the claim against the insured, who actually wronged the plaintiff.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Securities_Class_Action">Securities Class Action</a></td>
      <td>A securities class action (SCA), or securities fraud class action, is a lawsuit filed by investors who bought or sold a company’s publicly traded securities within a specific period of time (known as a “class period”) and suffered economic injury as a result of violations of the securities laws.  \nIn cases involving misleading statements or omissions, a class period generally starts when a company makes an untrue statement of material fact about the company or fails to disclose a material fact necessary to render other statements not misleading.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Kabushiki_gaisha">Kabushiki gaisha</a></td>
      <td>A kabushiki gaisha (Japanese: 株式会社, pronounced [kabɯɕi̥ki ɡaꜜiɕa]; literally "share company") or kabushiki kaisha, commonly abbreviated K.K., is a type of company (会社, kaisha) defined under the Companies Act of Japan.  The term is often translated as "stock company", "joint-stock company" or "stock corporation".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Directors_and_officers_liability_insurance">Directors and officers liability insurance</a></td>
      <td>Directors and officers liability insurance (also written directors' and officers' liability insurance; often called D&amp;O) is liability insurance payable to the directors and officers of a company, or to the organization itself, as indemnification (reimbursement) for losses or advancement of defense costs in the event an insured suffers such a loss as a result of a legal action brought for alleged wrongful acts in their capacity as directors and officers. Such coverage can extend to defense costs arising from criminal and regulatory investigations or trials as well; in fact, often civil and criminal actions are brought against directors and officers simultaneously.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Olympus_scandal">Olympus scandal</a></td>
      <td>The Olympus scandal was precipitated on 14 October 2011 when British-born Michael Woodford was suddenly ousted as chief executive of international optical equipment manufacturer Olympus Corporation. He had been company president for six months, and two weeks prior had been promoted to chief executive officer, when he exposed "one of the biggest and longest-running loss-hiding arrangements in Japanese corporate history", according to The Wall Street Journal.</td>
    </tr>
  </tbody>
</table>